Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MIND MEDICINE (MINDMED) INC.

(MNMD)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/12/2021 10/13/2021 10/14/2021 10/15/2021 10/18/2021 Date
2.34(c) 2.29(c) 2.36(c) 2.35(c) 2.29(c) Last
2 210 340 1 561 474 1 678 723 2 274 065 2 225 405 Volume
+5.88% -2.14% +3.06% -0.42% -2.55% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 - - -
Net income 2021 -82,9 M - -
Net cash position 2021 130 M - -
P/E ratio 2021 -12,1x
Yield 2021 -
Sales 2022 - - -
Net income 2022 -77,4 M - -
Net cash position 2022 74,2 M - -
P/E ratio 2022 -14,0x
Yield 2022 -
Capitalization 844 M 844 M -
EV / Sales 2021 -
EV / Sales 2022 -
Nbr of Employees 22
Free-Float 81,4%
More Financials
Company
Mind Medicine (MindMed) Inc. is a Canada-based clinical-stage psychedelic medicine biotechnology company. The Company focuses on discovering, developing and deploying psychedelic-inspired medicines and therapies to address addiction and mental illness. The Company's commercial drug development programs includes lysergic acid diethylamide (LSD) experiential therapy, 18-methoxycoronaridine (18-MC) opioid withdrawal,... 
More about the company
All news about MIND MEDICINE (MINDMED) INC.
10/13Mind Medicine Inc. Joins Clinical Trials Transformation Initiative
CI
10/05MIND MEDICINE MINDMED : MindMed to Jumpstart Research Collaboration With Sphere Health
MT
10/05Mind Medicine Inc. Announces Strategic Research Collaboration with Sphere Health
CI
10/04MIND MEDICINE MINDMED : Material Change Report (Form 6-K)
PU
09/30MIND MEDICINE MINDMED : MindMed Announces Appointment of Andreas Krebs and Carol Vallone a..
PU
09/30MIND MEDICINE MINDMED : MindMed Announces Appointment of Andreas Krebs and Carol Vallone a..
PR
09/30Mind Medicine Inc. Announces Executive Changes
CI
09/29Mind Medicine Inc. Announces Addition of Bryan L. Roth to its Scientific Advisory Board
CI
09/29MIND MEDICINE MINDMED : MindMed Appoints University of North Carolina Psychiatrist and Pha..
PR
09/28MIND MEDICINE MINDMED : MindMed to present at the Benzinga Healthcare Small Cap Conference
PR
09/23MIND MEDICINE MINDMED : Reports Results From Psychedelic Studies; Shares Rise Pre-Bell
MT
09/23MIND MEDICINE MINDMED : MindMed and Liechti Lab Provide Results from their Psilocybin R&D ..
PR
09/23Mind Medicine Inc. and Liechti Lab Provide Results from Psilocybin R&D Collaboration
CI
09/20MIND MEDICINE INC.(NASDAQCM : MNMD) added to S&P Global BMI Index
CI
09/13MIND MEDICINE MINDMED : MindMed to Present at H.C. Wainwright 23rd Annual Global Investmen..
AQ
More news
News in other languages on MIND MEDICINE (MINDMED) INC.
09/23Mind Medicine publie les résultats d'études sur les psychédéliques ; les actions monten..
07/23PLONGÉE DANS LE BUSINESS DES OCABSA : Interview de Pierre Vannineuse
2020IRW-NEWS : Mind Medicine Mindmed Inc. : MindMed erhält von Gesundheitsbehörden in Schweiz ..
2020IRW-PRESS : Mind Medicine Mindmed Inc. : MindMed -2-
2020IRW-PRESS : Mind Medicine Mindmed Inc. : MindMed erhält von Gesundheitsbehörden in Schweiz..
More news
Analyst Recommendations on MIND MEDICINE (MINDMED) INC.
More recommendations
Chart MIND MEDICINE (MINDMED) INC.
Duration : Period :
Mind Medicine (MindMed) Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MIND MEDICINE (MINDMED) INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 2,29 $
Average target price 6,71 $
Spread / Average Target 193%
EPS Revisions
Managers and Directors
Robert Barrow Chief Executive Officer
David D. Guebert Chief Financial Officer
Perry Nicholas Dellelce Chairman
Donald R. Gehlert Chief Scientific Officer
Bradford Cross Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
MIND MEDICINE (MINDMED) INC.-24.92%844
MODERNA, INC.220.51%135 157
LONZA GROUP AG27.29%58 232
IQVIA HOLDINGS INC.38.67%47 608
SEAGEN INC.-1.81%31 287
CELLTRION, INC.-39.69%24 952